(VIANEWS) – The NYSE ended the session with Teva Pharmaceutical (TEVA) jumping 4.85% to $7.89 on Monday while NYSE rose 1.03% to $14,636.76.


Today’s last reported volume for Teva Pharmaceutical is 9573740, 4.23% below its average volume of 9996720.

Teva Pharmaceutical’s last close was $7.89, 24.86% below its 52-week high of $10.50.

Teva Pharmaceutical’s Sales

Teva Pharmaceutical’s sales growth is a negative 3.7% for the ongoing quarter and a decline by 1.6% for the next.

Teva Pharmaceutical’s Revenue

Year-on-year quarterly revenue growth declined by 7.9%, now sitting on 15.88B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Teva Pharmaceutical’s stock is considered to be oversold (<=20).

Teva Pharmaceutical’s Stock Yearly Top and Bottom Value

Teva Pharmaceutical’s stock is valued at $7.89 at 18:58 EST, way below its 52-week high of $10.50 and higher than its 52-week low of $7.23.

Teva Pharmaceutical’s Moving Average

Teva Pharmaceutical’s worth is below its 50-day moving average of $8.57 and below its 200-day moving average of $8.75.

More news about Teva Pharmaceutical (TEVA).


Please enter your comment!
Please enter your name here